60,954 results on '"HYPOTHYROIDISM"'
Search Results
2. Energy Metabolism in Thyroidectomized Patients
- Author
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Published
- 2024
3. Natural History of Thyroid Function Disorders
- Published
- 2024
4. Pharmacist Role in Thyroid Disorders
- Author
-
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization, Marmara University, and Muhammed Yunus Bektay, Principal Investigator
- Published
- 2024
5. Impact Of Subclinical Hypothyroidism On Short-Term Outcomes In Patients With Acute Coronary Syndrome In Sohag University Hospitals
- Author
-
Amr Ibrahim Abd El-haleem Adam, Assistant lecturer internal medicine sohag university
- Published
- 2024
6. Insulin Resistance in Relation to Hyperthyroidism and Hypothyroidism
- Author
-
Dina Ibrahim Sadek Mohamed, Doctor
- Published
- 2024
7. Baby Detect : Genomic Newborn Screening
- Author
-
Centre Hospitalier Régional de la Citadelle, University of Liege, Sanofi, Orchard Therapeutics, Takeda, Zentech-Lacar Company, Leon Fredericq Foundation, and Laurent Servais, Professor
- Published
- 2024
8. Comparison of Aerobic and Resistance Training on Exercise Capacity, Depression and Quality of Life in Hypothyroidism.
- Published
- 2024
9. MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin (SHIELD)
- Author
-
Ashu Rastogi, Associate Professor
- Published
- 2024
10. Interventional Study to Improve Medication Adherence Using Patient Decision Aid (IMPART)
- Author
-
Kalaipriya Gunasekaran, Principal Investigator
- Published
- 2024
11. Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)
- Author
-
Cromsource
- Published
- 2024
12. The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
- Published
- 2024
13. Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage
- Author
-
Wei Junji, clinical professor
- Published
- 2024
14. Brain hypothyroidism silences the immune response of microglia in Alzheimers disease animal model.
- Author
-
Kim, Dong, Choi, Hyunjung, Lee, Woochan, Choi, Hayoung, Hong, Seok, Jeong, June-Hyun, Han, Jihui, Han, Jong, Ryu, Hoon, Kim, Jong-Il, and Mook-Jung, Inhee
- Subjects
Mice ,Animals ,Alzheimer Disease ,Microglia ,Amyloid beta-Peptides ,Brain ,Immunity ,Innate ,Hypothyroidism ,Models ,Animal ,Disease Models ,Animal - Abstract
Thyroid hormone (TH) imbalance is linked to the pathophysiology of reversible dementia and Alzheimers disease (AD). It is unclear whether tissue hypothyroidism occurs in the AD brain and how it affects on AD pathology. We find that decreased iodothyronine deiodinase 2 is correlated with hippocampal hypothyroidism in early AD model mice before TH alterations in the blood. TH deficiency leads to spontaneous activation of microglia in wild-type mice under nonstimulated conditions, resulting in lowered innate immune responses of microglia in response to inflammatory stimuli or amyloid-β. In AD model mice, TH deficiency aggravates AD pathology by reducing the disease-associated microglia population and microglial phagocytosis. We find that TH deficiency reduces microglial ecto-5-nucleotidase (CD73) and inhibition of CD73 leads to impaired innate immune responses in microglia. Our findings reveal that TH shapes microglial responses to inflammatory stimuli including amyloid-β, and brain hypothyroidism in early AD model mice aggravates AD pathology by microglial dysfunction.
- Published
- 2024
15. Impact of Thyroid Status on Incident Kidney Dysfunction and Chronic Kidney Disease Progression in a Nationally Representative Cohort.
- Author
-
You, Amy, Brent, Gregory, Narasaki, Yoko, Daza, Andrea, Sim, John, Kovesdy, Csaba, Nguyen, Danh, Kalantar-Zadeh, Kamyar, and Rhee, Connie
- Subjects
Humans ,Retrospective Studies ,Thyrotropin ,Hypothyroidism ,Hyperthyroidism ,Renal Insufficiency ,Chronic ,Kidney ,Thyroxine - Abstract
OBJECTIVE: To examine the relationship between thyroid status and incident kidney dysfunction/chronic kidney disease (CKD) progression. PATIENTS AND METHODS: We examined incident thyroid status, ascertained by serum thyrotropin (TSH) levels measured from January 1, 2007, through December 31, 2018, among 4,152,830 patients from the Optum Labs Data Warehouse, containing deidentified retrospective administrative claims data from a large national health insurance plan and electronic health record data from a nationwide network of provider groups. Associations of thyroid status, categorized as hypothyroidism, euthyroidism, or hyperthyroidism (TSH levels >5.0, 0.5-5.0, and 5.0-10.0, >10.0-20.0, and >20.0 mIU/L, respectively) were associated with increasingly higher risk of the composite end point (reference: TSH level, 0.5 to
- Published
- 2024
16. Early Check: Expanded Screening in Newborns
- Author
-
University of North Carolina, Chapel Hill, The John Merck Fund, Duke University, Wake Forest University, North Carolina Department of Health and Human Services, National Center for Advancing Translational Sciences (NCATS), Cure SMA, The National Fragile X Foundation, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Asuragen, Inc., Sarepta Therapeutics, Inc., Muscular Dystrophy Association, The Leona M. and Harry B. Helmsley Charitable Trust, Juvenile Diabetes Research Foundation, Janssen Pharmaceuticals, GeneDx, and Illumina, Inc.
- Published
- 2024
17. Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism
- Author
-
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy, lecturer and consultant at Obstetrics and Gynecology Department.
- Published
- 2024
18. Hypothalamic-pituitary Dysfunction in Diabetes (DIAPO)
- Author
-
Marco Bonomi, MD, Professor
- Published
- 2024
19. A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients (THYROID-HD)
- Author
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and Connie Rhee, Assistant Professor of Medicine and Public Health; Division of Nephrology and Hypertension, Department of Medicine
- Published
- 2024
20. Vitamin D & Levothyroxine Combination Versus Levothyroxine on Lipid Profile in Hypothyroidism (ViDaLLiT)
- Author
-
Sidrah Lodhi, Assistant Professor of Endocrinology
- Published
- 2024
21. Dosing of LT4 in Older Individuals (DOT4)
- Author
-
National Institute on Aging (NIA) and Anne Cappola, MD, Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism
- Published
- 2024
22. Thyroid Function and Structure IN Klinefelter Syndrome (THINKS)
- Author
-
Andrea M. Isidori, Full professor
- Published
- 2024
23. Hypothyroidism in Pregnancy and Neuropsychological Development in Children (OHPLDO)
- Published
- 2024
24. Comorbidities Resolution After MGB Surgery and Change in Body Composition (MOGAMBO)
- Author
-
Dr. Prakash Kumar Sasmal, Additional Professor of General Surgery
- Published
- 2024
25. Subclinical Hypothyroidism and Normogonadotropic Anovulation
- Author
-
Iwona Magdalena Gawron, Principal Investigator
- Published
- 2024
26. Subclinical Hypothyroidism and Chronic Inflammation in PCOS
- Author
-
Iwona Magdalena Gawron, Ph.D., Principal Investigator
- Published
- 2024
27. Throid Dysfunction in Liver Failure and Its Eddects Upon Outcome
- Author
-
Emad Zarief , MD, professor
- Published
- 2024
28. Effect of Vitamin C Supplementation in Patients With Primary Hypothyroidism
- Author
-
Dr Adnan Agha, Assistant Professor, Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University
- Published
- 2024
29. Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism
- Published
- 2024
30. Genetically predicted hypothyroidism, thyroid hormone treatment, and the risk of cardiovascular diseases: a mendelian randomization study.
- Author
-
Zhang, Shuaidan, Yu, Hangtian, Zhao, Yan, Gong, Angwei, Guan, Chengjian, Chen, Shuchen, Xiao, Bing, and Lu, Jingchao
- Abstract
Background: In this study, we explored the impact of hypothyroidism and thyroid hormone replacement therapy on the risk of developing cardiovascular diseases, including myocardial infarction, heart failure, and cardiac death, via Mendelian randomization analysis. Methods: Genetic instrumental variables related to hypothyroidism, levothyroxine treatment (refer to Participants were taking the medication levothyroxine sodium) and adverse cardiovascular events were obtained from a large publicly available genome-wide association study. Two-sample Mendelian randomization analysis was performed via inverse-variance weighting as the primary method. To ensure the reliability of our findings, we performed MR‒Egger regression, Cochran's Q statistic, and leave-one-out analysis. Additionally, multivariable Mendelian randomization was employed to regulate confounding factors, including systolic blood pressure (SBP), diastolic blood pressure (DBP), body mass index (BMI), diabetes, cholesterol, low-density lipoprotein (LDL), triglycerides and metformin. A mediation analysis was conducted to assess the mediating effects on the association between exposure and outcome by treating atrial fibrillation and stroke as mediator variables of levothyroxine treatment and bradycardia as mediator variables of hypothyroidism. Results: Genetically predicted hypothyroidism and levothyroxine treatment were significantly associated with the risk of experiencing myocardial infarction [levothyroxine: odds ratio (OR) 3.75, 95% confidence interval (CI): 1.80–7.80; hypothyroidism: OR: 15.11, 95% CI: 2.93–77.88]. Levothyroxine treatment was also significantly related to the risk of experiencing heart failure (OR: 2.16, 95% CI: 1.21–3.88). However, no associations were detected between hypothyroidism and the risk of experiencing heart failure or between hypothyroidism or levothyroxine treatment and the risk of experiencing cardiac death. After adjusting for confounding factors, the results remained stable. Additionally, mediation analysis indicated that atrial fibrillation and stroke may serve as potential mediators in the relationships between levothyroxine treatment and the risk of experiencing heart failure or myocardial infarction. Conclusion: The results of our study suggest a positive association between hypothyroidism and myocardial infarction and highlight the potential effects of levothyroxine treatment, the main thyroid hormone replacement therapy approach, on increasing the risk of experiencing myocardial infarction and heart failure. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Causal associations of hypothyroidism with frozen shoulder: a two-sample bidirectional Mendelian randomization study.
- Author
-
Chen, Bin, Zhu, Zheng-hua, Li, Qing, Zuo, Zhi-cheng, and Zhou, Kai-long
- Subjects
- *
GENOME-wide association studies , *ODDS ratio , *HYPOTHYROIDISM , *SENSITIVITY analysis , *CONFIDENCE intervals - Abstract
Background: Many studies have investigated the association between hypothyroidism and frozen shoulder, but their findings have been inconsistent. Furthermore, earlier research has been primarily observational, which may introduce bias and does not establish a cause-and-effect relationship. To ascertain the causal association, we performed a two-sample bidirectional Mendelian randomization (MR) analysis. Methods: We obtained data on "Hypothyroidism" and "Frozen Shoulder" from Summary-level Genome-Wide Association Studies (GWAS) datasets that have been published. The information came from European population samples. The primary analysis utilized the inverse-variance weighted (IVW) method. Additionally, a sensitivity analysis was conducted to assess the robustness of the results. Results: We ultimately chose 39 SNPs as IVs for the final analysis. The results of the two MR methods we utilized in the investigation indicated that a possible causal relationship between hypothyroidism and frozen shoulder. The most significant analytical outcome demonstrated an odds ratio (OR) of 1.0577 (95% Confidence Interval (CI):1.0057–1.1123), P = 0.029, using the IVW approach. Furthermore, using the MR Egger method as a supplementary analytical outcome showed an OR of 1.1608 (95% CI:1.0318–1.3060), P = 0.017. Furthermore, the results of our sensitivity analysis indicate that there is no heterogeneity or pleiotropy in our MR analysis. In the reverse Mendelian analysis, no causal relationship was found between frozen shoulders and hypothyroidism. Conclusion: Our MR analysis suggests that there may be a causal relationship between hypothyroidism and frozen shoulder. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Association between systemic lupus erythematosus and autoimmune thyroid dysfunction in pediatric population: a single center experience.
- Author
-
Shamma, Radwa Ahmed, Soliman, Hend Mehawed, Abdelfattah, Walaa, Badawy, Marwa Ahmed, and Shafie, Eman Shafik
- Subjects
- *
RISK assessment , *CROSS-sectional method , *PHYSICAL diagnosis , *MEDICAL history taking , *STATISTICAL correlation , *THYROID gland function tests , *DISEASE duration , *THYROID diseases , *SCIENTIFIC observation , *ENZYME-linked immunosorbent assay , *IMMUNOGLOBULINS , *SYSTEMIC lupus erythematosus , *SEVERITY of illness index , *GLOBULINS , *DESCRIPTIVE statistics , *AUTOIMMUNE diseases , *RESEARCH , *IMMUNOMODULATORS , *PEROXIDASE , *HYPOTHYROIDISM , *DISEASE risk factors , *DISEASE complications , *CHILDREN - Abstract
Background: Systemic Lupus Erythematosus (SLE) patients are more likely than the general population to suffer from thyroid illness. The major goal was to assess the thyroid dysfunctions due to immunological factors in Egyptian SLE children and how they are related to the course and severity of the illness. Methods: Fifty children and adolescents with SLE are included in this cross-sectional observational study. Every patient underwent a thorough physical examination and a comprehensive history taking. An enzyme-linked immunosorbent assay (ELISA) approach was used to evaluate the thyroid profile, anti-thyroglobulin (Anti-TG), and anti-thyroid peroxidase (anti-TPO) antibodies. Results: Of the 50 patients, the female: male ratio (F: M = 7:1) was 44 females and 6 males (12%). They were between the ages of 5 and 17. Out of the patients, thirty-two (64%) had thyroid dysfunctions, 19 (38%) had euthyroid sick syndrome, ten (20%) had overt hypothyroidism, three (6%) had subclinical hypothyroidism, and none had hyperthyroidism. Of the 50 patients, one (2%) had increased anti-TPO, whereas all other patients had normal anti-TG levels. A statistically significant negative correlation (p-value 0.007) was seen between the disease duration and free thyroxine (FT4). Furthermore, a significant negative correlation (p-values 0.015 and 0.028) was found when comparing the disease duration with thyroid antibodies (anti-TG and anti-TPO). Conclusion: In Juvenile Systemic Lupus Erythematosus (JSLE), thyroid dysfunctions can be identified. The disease duration but not its activity was significantly correlated with thyroid antibodies. For children with JSLE, thyroid function testing should be done on a regular basis. It is preferable to carry out additional thyroid antibody tests when necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Time-resolved interactome profiling deconvolutes secretory protein quality control dynamics.
- Author
-
Wright, Madison T, Timalsina, Bibek, Garcia Lopez, Valeria, Hermanson, Jake N, Garcia, Sarah, and Plate, Lars
- Subjects
- *
CONGENITAL hypothyroidism , *PROTEIN-protein interactions , *QUALITY control , *CONGENITAL disorders , *PROTEOMICS , *HOMEOSTASIS , *STREPTAVIDIN - Abstract
Many cellular processes are governed by protein–protein interactions that require tight spatial and temporal regulation. Accordingly, it is necessary to understand the dynamics of these interactions to fully comprehend and elucidate cellular processes and pathological disease states. To map de novo protein–protein interactions with time resolution at an organelle-wide scale, we developed a quantitative mass spectrometry method, time-resolved interactome profiling (TRIP). We apply TRIP to elucidate aberrant protein interaction dynamics that lead to the protein misfolding disease congenital hypothyroidism. We deconvolute altered temporal interactions of the thyroid hormone precursor thyroglobulin with pathways implicated in hypothyroidism pathophysiology, such as Hsp70-/90-assisted folding, disulfide/redox processing, and N-glycosylation. Functional siRNA screening identified VCP and TEX264 as key protein degradation components whose inhibition selectively rescues mutant prohormone secretion. Ultimately, our results provide novel insight into the temporal coordination of protein homeostasis, and our TRIP method should find broad applications in investigating protein-folding diseases and cellular processes. Synopsis: A new temporal proteomics technique reveals the protein interaction dynamics of folding and secretion pathways. The method clarifies how mutant forms of the pro-hormone thyroglobulin result in congenital hypothyroidism by elucidating the defects in protein quality control. TRIP combines pulsed unnatural amino acid labeling, biotin-streptavidin enrichment, and TMTpro-multiplexed proteomics to study time-resolved protein interactions. Secretion-defective thyroglobulin mutants exhibit prolonged interaction dynamics with chaperone, disulfide exchange, and degradation pathway interactions. Depletion of degradation factors VCP and TEX264 rescues mutant prohormone secretion. VCP inhibition shifts temporal protein interactions to rescue mutant thyroglobulin secretion. A new temporal proteomics technique reveals the protein interaction dynamics of folding and secretion pathways. The method clarifies how mutant forms of the pro-hormone thyroglobulin result in congenital hypothyroidism by elucidating the defects in protein quality control. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. The Role of Vitamin D Supplementation in Managing Thyroid Disorders: A Randomized Controlled Trial.
- Author
-
M. P., Abhishek, F., Sumaiya, C. P., Divakar Gowda, and P., Srinivas
- Abstract
Background: Thyroid disorders, including hypothyroidism, hyperthyroidism, and autoimmune thyroid diseases (AITDs) such as Hashimoto's thyroiditis and Graves' disease, are prevalent endocrine disorders with significant global health impacts. Emerging evidence suggests that vitamin D, known for its role in bone health and calcium metabolism, may also influence immune function and thyroid health. Objective: This study aimed to evaluate the efficacy of vitamin D supplementation in improving thyroid function and reducing autoimmune activity in individuals with thyroid disorders. Methods: This double-blind, randomized controlled trial (RCT) involved 200 participants diagnosed with thyroid disorders, including hypothyroidism, hyperthyroidism, and AITDs. Participants were randomly assigned to receive either vitamin D supplementation (50,000 IU/week for 8 weeks, followed by 2,000 IU/day for 10 months) or a placebo for 12 months. Primary outcomes included changes in serum 25-hydroxyvitamin D [25(OH)D] levels, thyroid function tests (TSH, Free T4, Free T3), and thyroid autoantibodies (anti-TPO, antiTG). Secondary outcomes included improvements in clinical symptoms and quality of life. Data were analyzed using SPSS version 25.0. Results: Participants in the intervention group exhibited a significant increase in serum 25(OH)D levels (from 18.5 ± 4.3 ng/mL to 35.2 ± 6.2 ng/mL, p < 0.001). This increase was associated with significant reductions in TSH levels (-1.2 ± 0.8 mIU/L, p < 0.001) and thyroid autoantibodies (anti-TPO: -30 ± 12 IU/mL, p < 0.001; anti-TG: -25 ± 10 IU/mL, p < 0.001). Improvements in Free T4 and Free T3 levels were also observed in the intervention group (p < 0.001). The control group showed no significant changes in these parameters. Participants in the intervention group reported greater improvement in clinical symptoms and quality of life. Conclusion: Vitamin D supplementation significantly improves thyroid function and reduces autoimmune activity in individuals with thyroid disorders, particularly those with hypothyroidism and AITDs. These findings suggest that vitamin D may serve as an effective adjunctive therapy in managing thyroid disorders. Further research is needed to confirm these results and explore the long-term benefits of vitamin D supplementation in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
35. Evaluation of Uric acid, Creatinine, BMI, EGFR in hypothyroid patients and euthyroid controls.
- Author
-
Jyothi, N., Murty, Goda Veena, Bhagyalakshmi, V., and Narayana, Thumma Sankara
- Abstract
Introduction Hypothyroidism is a clinical syndrome resulting from deficiency of thyroid hormone leading to generalised slowing down of metabolic process. The thyroid gland, located anterior to the trachea between the cricoid cartilage and the suprasternal notch, plays a pivotal role in maintaining thermogenic and metabolic homeostasis in adults by producing thyroxine (T4) and triiodothyronine (T3) hormones. Hypothyroidism is associated with reduced Glomerular Filtration Rate (GFR), increased serum creatinine, and alterations in water excretion. Haemodynamic changes in hypothyroidism contribute to elevated serum creatinine levels. Material and Methods This is a Case control study was conducted in the Department of Biochemistry at Rangaraya Medical College, Kakinada. 50 newly diagnosed hypothyroid patients attending department of General surgery were involved. Demographic information of cases and controls are noted in data collection Tables. BMI Is calculated. Sample collection: Study participants are advised to be on overnight fast and blood sample is collected in morning in labelled red top vacutainer for T3,T4,TSH. Results The mean level in cases (1.19 ng/mL) is higher compared to controls (0.73 ng/mL). The standard deviation in cases is also higher, indicating greater variability in T3 levels among cases. The mean level in cases (6.36 µg/dL) is significantly higher compared to controls (0.64 µg/dL), with a much larger standard deviation in cases. The mean TSH level in cases (33.92 µIU/mL) is considerably higher than in controls (1.77 µIU/mL). The standard deviation in cases is also larger, suggesting greater variability. The mean uric acid level in cases (6.28 mg/dL) is higher compared to controls (5.65 mg/dL). The standard deviation is slightly lower in cases (1.32) than in controls (1.55), suggesting that while cases have a higher average uric acid level, the variability among controls is somewhat greater. The mean creatinine level in cases (0.95 mg/dL) is higher compared to controls (0.58 mg/dL). The standard deviation is also higher in cases (0.27) compared to controls (0.24), indicating that creatinine levels vary more among cases. The mean eGFR level in cases (80.26 mL/min/1.73 m²) is lower compared to controls (92.78 mL/min/1.73 m²). The standard deviation is higher in cases (15.56) compared to controls (12.18), indicating greater variability in eGFR among cases. Conclusion Present study shows that there is increased uric acid levels and creatinine levels and decreased eGFR levels in study group as compared to control group. The prevalence of hyperuricemia is high in hypothyroidism. These changes in the biochemical values is because of the renal dysfunction evident by decrease in mean eGFR level as compared to mean eGFR level in control group. Thus, these findings are helpful in understanding the interaction between thyroid gland and kidney showing the detrimental effect of hypothyroid state on renal functioning. [ABSTRACT FROM AUTHOR]
- Published
- 2024
36. To evaluate the effect of hypothyroidism on the renal functions of the body.
- Author
-
Ali, Azghar, Naik, Danish Habib, Handoo, Vidushi, and Gupta, Abhinav
- Abstract
Introduction: The interactions between thyroid gland and renal functions are known for years. Thyroid dysfunction can affect renal physiology and development, and on the other hand, kidney disorders can influence thyroid function. Hence; the present study was done to evaluated the effect of hypothyroidism on the renal functions of the body Material and Methods: This one-year observational prospective study will be conducted in the Postgraduate Department of Internal Medicine, Government Medical College and Hospital, Jammu with effect from November, 2019 to October, 2020. Recording of detailed history including history of cardiovascular disease, diabetes mellitus, hypertension, surgery, or any drug intake and family history of renal, muscular, liver disorders. Measurement of anthropometric indices like weight, height, BMI. Recording of vital signs. Blood investigations including serum uric acid, serum creatinine, fT3, fT4 and TSH. The statistical analysis was done using (SPSS 22.00 for windows; SPSS inc, Chicago, USA). Results: In both the groups, females were comparatively more as compared to males. When mean creatinine and Uric Acid (mg/dl) was compared statistically among case and control group, it was found to be statistically significant as p<0.05.Positive significant correlation was found between TSH and creatinine (r=0.54, p=<0.01) and and uric acid (r=0.61, p=<0.01). Conclusion: This study confirms that hypothyroidism is associated with a consistent elevation in the serum creatinine and uric acid levels. Therefore, we would suggest assessment of thyroid function in patients presenting with deranged renal function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
37. A study of thyroid function abnormalities in patients with chronic kidney disease.
- Author
-
Moolrajani, Kishore, Patel, Manan, Bansal, Dharam Prakash, Rijhwani, Puneet, Sarna, Mukesh, Goyal, Aditi, Sharma, Saahil, Patel, Krunal, and Sharma, Harshit
- Abstract
Aims and objectives: A study was conducted at Department of General Medicine, Mahatma Gandhi Medical College and Hospital, Jaipur, India, to see prevalence of thyroid disorder in CKD patients. Material and methods: An Observational Cross-Sectional Study was conducted at Department of General Medicine, Mahatma Gandhi Medical College and Hospital form August 2022 to October 2023. Patients who were on conservative management fulfilling the criteria for chronic kidney disease admitted in Department of Medicine, Mahatma Gandhi Hospital, Jaipur Results: Euthyroid was present in 63% patients, Primary hypothyroidism was present in 11% patients and Subclinical hypothyroidism was present in 26% patients. CKD stage IV showed higher mean T3 value (0.94) as compared to CKD stage V (0.608). CKD stage V showed higher mean TSH value (6.69) as compared to CKD stage IV (4.21). CKD stage IV showed higher mean GFR value (18.17) as compared to CKD stage V (8.16). Mean eGFR value of euthyroid (9.76) was significantly higher than subclinical hypothyroidism (7.11) and primary hypothyroidism (6.25) among eGFR level. Primary hypothyroidism was present 87.5% in CKD stage V patients and Subclinical hypothyroidism was present 84.2%% in CKD stage V patients. Conclusion: The mean TSH value was greater in CKD stage V (6.69) than in CKD stage IV (4.21). The mean GFR value for CKD stage IV was greater than that of CKD stage V (8.16), at 18.17. Therefore, it is crucial to check for thyroid disorders in all patients with chronic renal disease, since they may negatively impact the prognosis of the illness as a whole. [ABSTRACT FROM AUTHOR]
- Published
- 2024
38. Assessment of Thyroid Gland in Children with Point-of-Care Ultrasound (POCUS): Radiological Performance and Feasibility of Handheld Ultrasound in Clinical Practice.
- Author
-
Anık, Ahmet, Gök, Mustafa, and Tuzcu, Göksel
- Subjects
- *
THYROID gland radiography , *ULTRASONIC imaging equipment , *STATISTICAL correlation , *ENDOCRINOLOGISTS , *HOSPITAL patients , *THYROID gland , *MEDICAL equipment , *ROOMS , *RESEARCH , *HYPERTHYROIDISM , *POINT-of-care testing , *COMPARATIVE studies , *CONFIDENCE intervals , *HYPOTHYROIDISM , *CHILDREN - Abstract
Objective: Point-of-Care Ultrasound (POCUS) refers to the use of portable ultrasound machines to perform quick and focused ultrasound examinations at a patient's bedside or point-of-care. POCUS can be performed by all health workers with specific training to use POCUS. The aim of this study was to investigate the radiological performance and feasibility of POCUS using a handheld ultrasound device (HHUSD) in children for examining the thyroid gland. Methods: A pediatric endocrinologist performed thyroid imaging in children referred to our hospital with suspected thyroid disease using an HHUSD. The same children underwent ultrasonography (US) imaging using the same device by the first radiologist, and a second radiologist performed thyroid US using an advanced high-range ultrasound device (AHUSD) (defined as the gold-standard method) within two hours. The data obtained by the three researchers were compared with each other. Results: This study included 105 patients [68.6% girls (n=72)] with a mean age 12.8±3.6 years. When the thyroid volume was evaluated, a strong correlation was found between the measurements of the three researchers (AA vs. MG: r=0.963, AA vs. GT: r=0.969, MG vs. GT: r=0.963, p<0.001). According to the Bland-Altman analysis for total thyroid volume, AA measured 0.43 cc [95% confidence interval (CI): -0.89-0.03] smaller than MG, and 0.11 cc (95% CI: -0.30-0.52) larger than GT, whereas MG measured 0.52 cc (95% CI: 0.09-0.94) larger than GT. When evaluated for the presence of goiter and nodules, a near-perfect agreement was found between the results of the three researchers (AA vs. GT; κ=0.863, MG vs. GT; κ=0.887, p<0.001, and AA vs. GT; κ=1.000, MG vs. GT; κ=0.972, p<0.001, respectively). When evaluated in terms of the longest axis of nodules, a high correlation was found between the measurements of the three researchers (AA vs. MG; r=0.993, AA vs. GT; r=0.996, MG vs. GT; r=0.996, p<0.001). When evaluated in terms of the final diagnosis, the evaluations of the three researchers showed excellent agreement with each other (AA vs. GT; κ=0.893, MG vs. GT; κ=0.863, p<0.001, accuracy rate AA vs. GT: 93.3%; MG vs. GT: 91.4%). Conclusion: A pediatric endocrinologist, equipped with sufficient training in thyroid US evaluation, incorporated HHUSD examination as a routine clinical tool in an outpatient setting. It was shown that, they could effectively assess normal thyroid tissue in pediatric patients. Moreover, the HHUSD proved to be useful in detecting thyroid pathologies. However, it is important to note that for a more comprehensive evaluation of thyroid nodules, including detailed assessment and Thyroid Imaging Reporting and Data System (TIRADS) classification, patients should be referred to radiology departments equipped with AHUSD systems. These specialized devices, along with the expertise of radiologists, are essential for in-depth evaluations and accurate classification of thyroid nodules. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. Prevalence and risk factors of osteopenia and osteoporosis among postmenopausal women: A cross‐sectional study from Jordan.
- Author
-
Khurmah, Manar H. Abu, Alkhatatbeh, Mohammad J., Alshogran, Osama Y., and Alarda, Hamza M.
- Subjects
- *
OSTEOPENIA , *RISK assessment , *PHOTON absorptiometry , *LIFESTYLES , *CROSS-sectional method , *SUNSHINE , *PEARSON correlation (Statistics) , *RESEARCH funding , *ACADEMIC medical centers , *BONE density , *DATA analysis , *BODY mass index , *HYPERTENSION , *LOGISTIC regression analysis , *INTERVIEWING , *QUESTIONNAIRES , *CALCIUM carbonate , *POSTMENOPAUSE , *DESCRIPTIVE statistics , *CHI-squared test , *AGE distribution , *CHOLECALCIFEROL , *MEDICAL records , *LUMBAR vertebrae , *FEMUR , *AEROBIC exercises , *ONE-way analysis of variance , *STATISTICS , *WOMEN'S health , *SOCIODEMOGRAPHIC factors , *PROTON pump inhibitors , *CONFIDENCE intervals , *DATA analysis software , *DIABETES , *HYPOTHYROIDISM , *DISEASE risk factors - Abstract
Objectives: Our aim was to predict the prevalence of osteopenia and osteoporosis and their associated risk factors among postmenopausal women from Jordan. Methodology: In this cross‐sectional study, a total of 368 postmenopausal women were recruited from King Abdullah University Hospital (KAUH) in the North of Jordan between September 2022 and April 2023. Bone mineral density (BMD) was measured using a dual‐energy X‐ray absorptiometry scan. T‐score was used for osteoporosis diagnosis in accordance with the International Society for Clinical Densitometry (ISCD) guidelines. Data about sociodemographic and lifestyle variables were collected using face‐to‐face interviews. Medical records were used to retrieve participants' BMD information. Predictors of osteoporosis were identified using logistic regression. Results: Prevalence of osteoporosis was 40.5%, while 44.6% of participants were diagnosed with osteopenia. The lumbar spine had the highest frequency of osteoporosis (30.4%), while the left femoral neck had the highest prevalence of osteopenia (46.3%). Postmenopausal women's age (p‐value =.024), and history of chronic diseases (p‐value =.038) were significant factors associated with increased osteoporosis risk. Conclusions: Postmenopausal women from Jordan had high prevalence of osteoporosis and osteopenia. It is therefore necessary to target risk factors leading to osteoporosis and to improve patients' lifestyles through patient education. Healthcare systems should consider early screening approaches for osteoporosis at the age of menopause and thereafter. Supplements of calcium and vitamin D may be routinely considered for this age group depending on their serum levels. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. The Spectrum of Thyroid Dysfunction During Pregnancy and Fetomaternal Outcome, A Study from the Premier Institute of Western India.
- Author
-
Debbarma, Ranesh, Gothwal, Meenakshi, Singh, Pratibha, Yadav, Garima, Purohit, Purvi, Ghuman, Navdeep Kaur, and Gupta, Neeraj
- Subjects
- *
PEARSON correlation (Statistics) , *THYROID diseases , *SCIENTIFIC observation , *HYPERTENSION , *FETAL growth retardation , *PREGNANCY outcomes , *TERTIARY care , *CHI-squared test , *DESCRIPTIVE statistics , *THYROID hormones , *MEDICAL screening , *DATA analysis software , *HYPOTHYROIDISM ,DEVELOPING countries - Abstract
Background: Thyroid dysfunction evaluation during pregnancy is important for the mother's health, obstetric outcomes, and the child's cognitive development. This study is conducted to know various thyroid disorders that can occur during antenatal and their impact on mother and fetus outcomes. Materials and Methods: This observational research was conducted over two years at a tertiary center in Western Rajasthan, India. Seven hundred and seventy-two low-risk singleton pregnant patients who met the inclusive criteria were recruited. The estimation of T3, T4, and TSH was done along with a routine investigation in antenatal women. Antenatal having abnormal thyroid profiles were then analyzed for mother and fetus problems. Results: The prevalence of thyroid dysfunction in antenatal women is 16.5%. Subclinical hypothyroidism (SCH) was seen in 12.5% of cases, overt hypothyroidism in 3.36%, and subclinical hyperthyroidism in only 0.51% of cases. Anti-TPO was positive in 46 (41.44%) women with hypothyroidism and 1 (25%) with hyperthyroidism. Compared to euthyroid women, women with overt hypothyroid (19.23% vs 3.1%, P = 0.002) and subclinical hypothyroid (9.27% vs 3.1%, P = 0.003) were found to be associated with a higher risk of hypertensive disease. Concerning fetal outcomes. There was a high risk for preterm (12.37% v/s 4.9%, P = 0.004) and fetal growth retardation (FGR) in patients with SCH (7.21% v/s 3.1%, P = 0.04). Conclusion: Considering the significant influence of thyroid disorders on mother and fetus outcomes, the screening for thyroid during pregnancy should be considered universally, particularly in developing countries with high prevalent rates, such as India. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Pattern and Predictors of Thyroid Dysfunction among Pediatric Endocrine Referrals at the Tertiary Care Center of Northern India: A Longitudinal Study.
- Author
-
Sood, Mona, Bhat, Moomin Hussain, Masoodi, Shariq R., and Ahmad, Peerzada O.
- Subjects
- *
ENDOCRINOLOGY , *THYROXINE , *PUBERTY , *THYROID diseases , *SCIENTIFIC observation , *AUTOANTIBODIES , *ENDOCRINOLOGISTS , *SEX distribution , *CHILDREN'S hospitals , *TERTIARY care , *SYMPTOMS , *FAMILY history (Medicine) , *DESCRIPTIVE statistics , *LONGITUDINAL method , *HYPERTHYROIDISM , *ANTHROPOMETRY , *THYROTROPIN , *JUDGMENT (Psychology) , *MEDICAL referrals , *HYPOTHYROIDISM , *IMMUNITY , *DISEASE risk factors , *CHILDREN - Abstract
Postiodization era has experienced a change in pediatric thyroid disorders with autoimmune disorders and subclinical hypothyroidism (SCH) now more frequently diagnosed. The aims of this study were to evaluate the clinical spectrum of thyroid disorders among children referred to us, to ascertain characteristics that influence treatment, and to follow them for various outcome measures. An observational longitudinal study where all treatment-naïve children (<18 years) with suspected thyroid disorders were recruited. Data collected were anthropometry, serum TSH, TT4, TT3, antithyroid autoantibodies, family history, and clinical symptoms. The management was based on the clinical judgment of the endocrinologist with the first follow-up at six weeks and subsequent visits three monthly for one year. A total of 241 subjects aged 28 days to 17 years were included. Overall, SCH was the most common abnormality (39%) detected among subjects, followed by overt hypothyroidism (OH) (33%), congenital hypothyroidism (CH) (18%), and overt thyrotoxicosis (5%). A total of 85.5% (n = 204) of subjects were treated and in follow-up, 81% of them were found to be adequately managed. Comparative analysis of OH and SCH revealed pubertal age, female predominance, and the presence of autoimmunity (positive anti-TPO and anti-TG Ab) statically significant variables in the OH group. A major independent predictor of treatment in treated SCH (72/96) in comparison with nontreated SCH (24/96) was anti-TPO positivity (P = 0.029). Eight of 24 nontreated SCH were eventually treated in follow-up and positive family history was observed as a significant variable among them (P < 0.05). Subjects with CH presented at a mean age of 6 months (28 days to 2 years). However, guidelines for the management of SCH are still evolving, autoimmunity and positive family history should be considered as decisive factors while initializing treatment. Delayed presentation of CH in our study warrants active surveillance of children at birth for thyroid disorders for their mental well-being. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Importance of right communication with healthcare providers and patients about the new levothyroxine formulation: an expert opinion from Asia Pacific Thyroid Advisory Board.
- Author
-
Razvi, Salman, Nicodemus, Nemencio, Ratnasingam, Jeyakantha, Arundhati, Dasgupta, Soh, Wah Ek Abel, Kunavisarut, Tada, Zufry, Hendra, Chaudhari, Harshal, and Markova, Alina
- Subjects
- *
MEDICAL personnel , *THYROTROPIN , *RIGHT to health , *SAFETY standards , *ADVISORY boards - Abstract
Levothyroxine (LT4), being "narrow therapeutic index" drug, may lead to significant fluctuations in thyroid stimulating hormone (TSH) levels. Such fluctuations can result in clinically noteworthy disruptions in thyroid function and give rise to adverse clinical consequences. Consequently, regulatory standards for LT4 potency have been tightened, with the most stringent specifications requiring maintenance of potency within the range of 95–105% of the labeled dose throughout the entire shelf-life of the product. The LT4 new formulation with tightened specification adheres to these rigorous standards, demonstrating established bioequivalence to its older formulation while upholding an equivalent standard of safety and efficacy. Furthermore, the novel formulation exhibits enhanced stability and an extended shelf-life. Of paramount significance is its capacity to provide patients with accurate and consistent dosing, thereby effectively catering to their medical requirements. The primary objective of the Asia-Pacific advisory board meeting (held in June 2022 with endocrinologists, experts from India, Indonesia, Philippines, Thailand, Malaysia and Singapore) was to establish the importance of appropriate communication to HCPs, patients and other stakeholders regarding the LT4 new formulation. The aim of this brief review is to highlight the importance of communication with healthcare professionals that should focus on providing accurate information on the LT4 new formulation, emphasizing efficacy, safety, and bioequivalence with clear guidance and ensure that patients and clinicians are fully informed about any changes to medications such as LT4 to reduce the risk of unrelated adverse events being incorrectly attributed to the newer formulation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Assessing the relationship between psoriasis and thyroid dysfunction through two sample MR analysis.
- Author
-
Zheng, Hongkai, Li, Wei, Liang, Jingyao, and Zhang, Sanquan
- Abstract
Background: The association between psoriasis and hyperthyroidism/hypothyroidism remains inconclusive, with conflicting findings in prior studies. Objectives: This study employs Mendelian randomization methods to assess the potential relationship. Methods: Given the inability to accurately observe the link between psoriasis and thyroid dysfunction, we prioritized utilizing known genetic variants to investigate the potential impacts of the disease.We analyzed data from genome-wide association studies (GWASs), FinnGen, and UK Biobank to extract information on psoriasis, hyperthyroidism, and hypothyroidism. Three MR approaches (MR Egger, weighted median, and inverse variance weighted) were used to scrutinize the causal link. Results: Our analysis revealed no correlation between psoriasis and hyperthyroidism/hypothyroidism. However, vulgar psoriasis and guttate psoriasis were associated with hypothyroidism/myxedema (IVW odds ratio (OR) = 1.00, 95% confidence interval (CI) = 1.00–1.00, P = 2.53E-03), and Graves’ disease (IVW OR = 0.86, 95% CI = 0.72–1.01, P = 4.75E-02).In a subsequent analysis, we observed that hypothyroidism with mucinous edema showed no correlation with Graves’ disease in the opposite(P = 9.33E-01). Conclusion: This MR analysis suggests no association between psoriasis and thyroid dysfunction, but highlights associations of vulgar/guttate psoriasis with hypothyroidism/myxedema and Graves’ disease. In clinical practice, diagnosing guttate psoriasis requires vigilance for associated risks from hypothyroidism and Graves’ disease. For patients with both vulgar psoriasis and hypothyroidism, careful monitoring for mucinous edema is crucial, as it may signal a hypothyroid crisis. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Thyroid Diseases After Total Knee Replacement: A Multi-center, Propensity-score-matched Cohort Study.
- Author
-
CHEN-PI LI, SHAO-WEI LO, CHRISTINE HSU, YUN-FENG LI, RU-YIN TSAI, HUI-CHIN CHANG, and SHUO-YAN GAU
- Abstract
Background/Aim: Thyroid diseases are prevalent endocrine disorders that significantly affect overall health. Although the impact of pre-existing thyroid dysfunction on total knee replacement (TKR) outcomes has been studied, the potential for TKR to increase the risk of developing thyroid disorders remains unexplored. Patients and Methods: We examined electronic medical records from a large U.S. research network in the TriNetX research network. The study focused on patients with osteoarthritis, comparing those who had total knee replacement surgery (TKR) between 2005 and 2018 to a non-TKR group who did not have the surgery. Propensity score matching was employed to control for critical confounders. The hazard ratios (HRs) for the risk of thyroid diseases in TKR patients versus non-TKR controls were assessed. Results: Postmatching, the TKR cohort demonstrated a significantly higher risk of developing thyroid diseases compared to the non-TKR cohort (unadjusted HR=1.218, 95%CI=1.169-1.269). This elevated risk persisted after adjusting for confounders (adjusted HR=1.126, 95%CI=1.061-1.196). Stratification analysis indicated that female TKR patients and those aged ≥65 years were at higher risk of developing thyroid diseases than their respective control groups. Conclusion: This study suggests a potential link between TKR and an increased risk of thyroid diseases, particularly among older adults and females. Potential mechanisms include inflammatory processes, surgical stress, autoimmune responses, and pharmacological effects. Healthcare providers should be vigilant in monitoring and managing thyroid dysfunction in TKR patients. Further research is necessary to elucidate the underlying mechanisms and develop preventive strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
45. Arrhythmien bei Schilddrüsenerkrankungen.
- Author
-
Brenner, Roman, Bilz, Stefan, Busch, Sonia, Rickli, Hans, Ammann, Peter, and Maeder, Micha T.
- Abstract
Copyright of Herzschrittmachertherapie und Elektrophysiologie is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
46. Association of vitamin A with gestational diabetes and thyroid disorders in pregnancy and their influence on maternal, fetal, and neonatal outcomes.
- Author
-
Qadeer, Abdul, Ishaq, Muhammad Umer, Safi, Adnan, Akbar, Anum, Asif, Sana, Komel, Aqsa, Kunwar, Digbijay, and Bokhari, Syed Mujtaba Azhar
- Subjects
- *
RISK assessment , *VITAMIN A , *GESTATIONAL diabetes , *THYROID diseases , *PREGNANCY outcomes , *PREGNANT women , *NUTRITIONAL requirements , *VITAMINS , *HYPERTHYROIDISM , *PREGNANCY complications , *FETAL development , *DIETARY supplements , *HYPOTHYROIDISM , *PREGNANCY - Abstract
Gestational diabetes mellitus (GDM) and thyroid disorders during pregnancy pose significant health concerns, impacting a substantial number of mothers globally. Globally, about 14% of pregnant women develop GDM, while thyroid disorders impact approximately 2%–3%. Both conditions contribute to adverse outcomes, including gestational hypertension, excessive fetal growth, and heightened perinatal morbidity. The central focus of this literature review is to examine the relationship between vitamin A, a crucial fat-soluble micronutrient in fetal development, and the occurrence of GDM and thyroid disorders during pregnancy. The primary research question investigates the association between vitamin A, GDM, and thyroid disorders, analyzing their combined impact on maternal, fetal, and neonatal outcomes. The review underscores the potential of vitamin A to modulate the risk and outcomes of GDM and thyroid disorders during gestation, emphasizing its role in GDM development and resolution and its influence on thyroid function in pregnancy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Correlation of serum thyrotropin and thyroid hormone levels with diabetic kidney disease: a cross-sectional study.
- Author
-
Gao, Jie and Liu, Jingfang
- Subjects
- *
DIABETES complications , *CROSS-sectional method , *THYROXINE , *PREDICTIVE tests , *ALBUMINURIA , *RECEIVER operating characteristic curves , *BODY mass index , *GLYCOSYLATED hemoglobin , *RESEARCH funding , *DIABETIC nephropathies , *LOGISTIC regression analysis , *SEX distribution , *DESCRIPTIVE statistics , *AGE distribution , *THYROID hormones , *ODDS ratio , *CHOLESTEROL , *THYROTROPIN , *CONFIDENCE intervals , *ALBUMINS , *BIOMARKERS , *GLOMERULAR filtration rate , *HYPOTHYROIDISM , *C-reactive protein - Abstract
Objective: The relationship between thyrotropin (TSH), free triiodothyronine (FT3), free thyroxine (FT4) and diabetic kidney disease (DKD) is still controversial, and this study analyzed the correlation between TSH, FT3, FT4 and DKD in patients with type 2 diabetes mellitus (T2DM). Methods: T2DM patients (1216) were divided into five groups based on serum TSH, FT3, and FT4 levels, differences in urinary albumin excretion rate (UACR), estimated glomerular filtration rate (eGFR) were compared. Binary logistic regression verified independent correlations among TSH, FT3, FT4 and UACR, eGFR. TSH and FT3 predictive values for DKD were analyzed using receiver operating characteristic (ROC) curves. Results: The prevalence of albuminuria with decreased eGFR was higher in T2DM patients with subclinical hypothyroidism and overt hypothyroidism than that in patients with normal thyroid function. TSH positively correlated with UACR (r = 0.133, p < 0.001) and positively correlated with eGFR (r = -0.218, p < 0.001), FT3 negatively correlated with UACR (r = -0.260, p < 0.001) and positively correlated with eGFR (r = 0.324, p < 0.001). With the change from the lower normal level to the increased level of TSH and the change from the higher normal level to the reduced level of FT3, the prevalence of albuminuria gradually increased, the prevalence of decreased eGFR gradually increased in TSH groups and FT3 groups. After adjusting for age, BMI, duration of diabetes, TPOAb, TGAb, smoking, drinking, hypertension, the use of anti-diabetic medications (metformin, sodium–glucose cotransporter 2 inhibitors), HbA1c, CRP, TC, TG, LDL-C, and HDL-C, both TSH and FT3 correlated with increased UACR (TSH: OR 1.253, p = 0.001; FT3: OR 0.166, p < 0.001) and decreased eGFR (TSH: OR 1.245, p < 0.001, FT3: OR 0.579, p < 0.001), but this correlation of TSH with eGFR < 60 mL/min/1.73 m2 was not found in male. The area under the ROC curve (AUC) for FT3 was greater than that for TSH (FT3: 0.64; TSH: 0.61). Conclusions: Increased TSH and reduced FT3 levels were associated with DKD in T2DM patients, but in a sex-dependent manner. FT3 had a higher predictive value for DKD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Evaluation of the risk of hypothyroidism and its clinical manifestations using the Zulewski scale.
- Author
-
Ferreira-Hermosillo, Aldo, Toledo, Juan Omar, and Cordoba, Karla
- Subjects
THYROID diseases ,MEXICANS ,SYMPTOMS ,DISEASE prevalence ,HYPOTHYROIDISM - Abstract
Background: Globally, clinical hypothyroidism affects an estimated 0.5 to 5% of the population, while subclinical hypothyroidism affects 5-20%. Limited data is available on the prevalence of thyroid disease within the Mexican population. The objective of this study was to describe the characteristics of people screened for hypothyroidism in Mexico during 2022 using the Zulewski scale. Methods: A cross-sectional analysis was conducted using data obtained from a digital survey administered by an e-Health platform. This study included participants of all genders, aged 18 years and older (n = 31,449). Descriptive statistics (frequencies and percentages) were sued to describe the data. Differences between groups were assessed through the chi-square or Fischer’s exact test. Information gathered was subjected to hierarchical segmentation analysis to explore trends and patterns. Statistical significance was set as <0.05. Results: Among the participants, 87.7% were women, and 80% fell within the age group 18 and 44 years. According to the Zulewski scale, 27% of the participants had a low risk of hypothyroidism, 37.4% were classified as having an intermediate risk, and 35.6% were at a high risk. In people at high risk of hypothyroidism, the most common symptom was constipation (29.2%) whereas the most common sign was decreased speed of movement (26.2%). Inquiry of slow movements, dry skin, and facial edema allowed the identification of 90.2% of participants at high risk of hypothyroidism. Conclusions: In Mexico, a significant portion of the population is at an intermediate or high risk of hypothyroidism, requiring confirmatory diagnostic tests. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Triiodothyronine levels in athyreotic pediatric patients during levothyroxine therapy.
- Author
-
Baran, Julia, Isaza, Amber, Bojarsky, Mya, Alzoebie, Lama, Minkeun Song, Halada, Stephen, Sisko, Lindsay, Gonzales, Stephanie, Mostoufi-Moab, Sogol, and Bauer, Andrew J.
- Subjects
CHILD patients ,THYROID gland function tests ,QUALITY of life ,THYROID hormones ,THYROID cancer - Abstract
Objective: Levothyroxine (LT
4 ) monotherapy is the current recommended approach for treating pediatric patients post-total thyroidectomy (TT) based on the assumption that peripheral conversion of thyroxine (T4 ) to triiodothyronine (T3 ) normalizes thyroid hormone levels. In adults, approximately 15% of post-TT patients on LT4 monotherapy have altered T4:T3 ratios with ongoing debate in regard to the clinical impact with respect to health-related quality of life (hrQOL). The ability to normalize T3 and T4 levels on LT4 monotherapy for pediatric patients' post-TT is important but not previously described. This study reports data on T3 levels in athyreotic pediatric patients to determine if a similar cohort of patients exists on LT4 monotherapy targeting normalization of TSH (LT4 replacement) or suppression (LT4 suppression). Methods: Thyroid function tests (TFTs) were retrospectively extracted from medical charts for patients <19 years old who underwent TT for definitive treatment of Graves' disease (GD) or differentiated thyroid cancer (DTC) between 2010-2021. LT4 dosing was selected to normalize the TSH in GD patients (LT4 replacement) or suppress TSH in DTC patients (LT4 suppression). Pre- and post-surgical TSH, T3 and T4 levels were compared. Results: Of 108 patients on LT4 replacement (n=53) or LT4 suppression (n=55) therapy, 94% (102/108) of patients demonstrated T3 levels in the normal range post-TT. However, the majority of patients on LT4 replacement (44/53; 83%) and LT4 suppression (31/55; 56%) displayed post-TT T3 levels in the lower half of the normal range despite 50% (22/44) and 48% (15/31) of these patients, respectively, having post-TT fT4 levels above the upper limit of the normal range. Conclusion: A significant number of pediatric patients do not achieve similar T3 and T4 :T3 levels pre- and post-TT. Future multi-center, prospective studies evaluating LT4 monotherapy in comparison to combined LT4 /LT3 therapy are warranted to determine the potential clinical impact of altered T3 levels in athyreotic pediatric patients. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
50. Artemisinin ameliorates thyroid function and complications in adult male hypothyroid rats via upregulation of the L1 cell adhesion molecule.
- Author
-
Li, Lingling, Xu, Haifan, Hu, Zecheng, and Li, Li
- Subjects
- *
CELL adhesion molecules , *LABORATORY rats , *SMALL interfering RNA , *ARTS endowments , *OXIDATIVE stress - Abstract
Background: Hypothyroidism, a common worldwide syndrome caused by insufficient thyroid hormone secretion, affects number of people at different ages. Artemisinin (ART), a well-known effective agent in the treatment of malaria, also has anti-oxidative stress functions in various diseases. The L1 cell adhesion molecule exerts multiple protective roles in diseased systems. The aim of the present study was to evaluate the role of ART in adult male hypothyroid rats and the underlying mechanisms. Methods: The propylthiouracil (PTU) rat model was treated with or without 5 mg/kg ART and with or without L1 short-interfering RNA (siRNA), followed by the experiments to determine the effect of ART on thyroid function, depression and anxiety, cognition impairments, liver, kidney and heart functions, and oxidative stress. Results: In the current study, it was shown that ART can ameliorate thyroid function, mitigate depression and anxiety symptoms, attenuate cognition impairments, improve liver, kidney and heart functions, and inhibit oxidative stress; however, the effects exerted by ART could not be observed when L1 was silenced by L1 siRNA. Conclusion: These results indicated that ART can upregulate the L1 cell adhesion molecule to ameliorate thyroid function and the complications in adult male hypothyroid rats, laying the foundation for ART to be a novel strategy for the treatment of hypothyroidism. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.